Dr GIRI G.V.

MD, DMRT, DNB

Consultant-Radiation Oncologist/Senior Professor

Doctor's Message 

The SSCHRC is an institution dedicated to proividing real services to cancer patients.It is my honour to be a part of this institution.

Languages spoke 

English,Hindi,Kannada and Telugu

Areas of Interest 

Translational research in Head and Neck Cancer, Cervical cancer

Publications

1. Karthik S. Rishi, Nivedita Sarkar, Prashanth kesari, Muddappa Pathikonda, Prakash Ramachandra, Pradeep kumar Reddy Donapati, G.V. Giri, and Dr B.S. Srinath. Single Institution Experience of Postoperative Electron Beam Radiation Therapy in the treatment of keloids. Advances in Radiation Oncology. 2020 Oct.21;6(2):100596. https://doi.org/10.1016.j.adro.2020.10.009.

2.R Nanda, Aradhana Katke, N Suneetha, B Thejaswini, Tanvir Pasha, KP Jagannath, G.V. Giri, K. Govind Babu. A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly Cisplatin in locally advanced oropharyngeal carcinoma. South Asian Journal of Cancer 2019, vol.8. issue 3, 178-182.

3. Dr Aradhana K, Dr Thejaswini B, Dr Sham Sunder, Dr Usha Amritham, Dr R. Nanda, Dr G.V. Giri. Rosai Dorfman Disease- Five years Retrospective Analysis from Tertiary Cancer Centre; G.J.O. Issue 26, 2018; 11-17.

4. Ammothumkandy A, 1, Maliekal T.T., Bose M.V., Sundar Singh S.S., Rajkumar T., Thejaswini B, Giri G.V., and Krishna, S (2016). CD66 and CD49F expressing cells are associated with distinct neoplastic phenotypes and progression in human cervical cancer. European Journal of Cancer,60, 166-178.

5. Thejaswini B, Nanda R, Aradhana K, Ashalatha, Giri G.V. Shamsundar. Hyperfractionated radiotherapy and concurrent chemotherapy in locally advanced hypopharyngeal cancers- An Institutional Experience: IJMRR Jun 2016 vol 4 issue Pg 1017-23.

Hobbies

High Altitude Trekking,Scuba Diving and Golf